The data that led Cellular Intelligence to pick up Novo's Parkinson's stem cell therapy

Summary

Cellular Intelligence acquired Novo Nordisk's Parkinson's stem cell therapy program following the Danish pharma's closure of its cell therapy unit. Due diligence was conducted by neurologist and drug developer Nuno Mendonça.